Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Inventory (2018 - 2025)

AVITA Medical filings provide 8 years of Inventory readings, the most recent being $6.9 million for Q4 2025.

  • On a quarterly basis, Inventory fell 4.72% to $6.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.9 million, a 4.72% decrease, with the full-year FY2025 number at $6.9 million, down 4.72% from a year prior.
  • Inventory hit $6.9 million in Q4 2025 for AVITA Medical, down from $7.2 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $8.4 million in Q1 2025 to a low of $1.6 million in Q2 2021.
  • Median Inventory over the past 5 years was $3.7 million (2023), compared with a mean of $4.4 million.
  • Biggest five-year swings in Inventory: fell 6.86% in 2021 and later soared 163.34% in 2023.
  • AVITA Medical's Inventory stood at $2.1 million in 2021, then decreased by 0.33% to $2.1 million in 2022, then soared by 163.34% to $5.6 million in 2023, then grew by 29.9% to $7.3 million in 2024, then dropped by 4.72% to $6.9 million in 2025.
  • The last three reported values for Inventory were $6.9 million (Q4 2025), $7.2 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.